We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Annual trends in Medicare part D prescription claims for calcipotriene/betamethasone dipropionate foam for psoriasis 2016–2020.
- Authors
Smith, Brandon; Oulee, Aislyn; Devjani, Shivali; Collier, Michael R.; Egeberg, Alexander; Wu, Jashin J.
- Abstract
We investigated the trends of Cal/BD foam utilization among prescribers in the Medicare population using the 2016 to 2020 Medicare part D prescriber datasets. Nonetheless, the results provide insight into the prescription patterns of Cal/BD foam and potentially comparable patterns among commercial insurance patients. Annual claims were normalized (total claims per 100,000 national Medicare part D beneficiaries) by dividing the total claims by the total number of Medicare part D beneficiaries in each stated year.
- Subjects
MEDICARE Part D; DERMATOLOGISTS; FOAM; BETAMETHASONE; MEDICARE; PSORIASIS
- Publication
International Journal of Dermatology, 2023, Vol 62, Issue 8, pe443
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/ijd.16545